3D Cell Culture: SelectScience Special Feature
Keep up to date with the latest research and discover the tools advancing 3D cell culture and its applications
Source: selectscience.net
Tumor Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tumor Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tumor Models Today - Breaking & Trending Today
3D Cell Culture: SelectScience Special Feature
Keep up to date with the latest research and discover the tools advancing 3D cell culture and its applications
Source: selectscience.net
Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021
Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021 - BT7480 to be presented in a “New Drugs on the Horizon” session; on-track to enter the clinic in 2H’21 CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle®) technology, today announced that for the first time, preclinical work describing the discovery of BT7480, a novel Nectin-4/CD137 tumor-targeted immune cell agonis...
Source: pharmiweb.com
Bicycle Therapeutics plc: Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021
Bicycle Therapeutics plc: Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021 - BT7480 to be presented in a "New Drugs on the Horizon" session; on-track to enter the clinic in 2H'21 Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle) technology, today announced that for the first time, preclinical work describing the discovery of BT7480, a novel Nectin-4/CD137 tumor-targeted immune cell agonist (TICA TM), will be presented virtually in a "New D...
Source: finanznachrichten.de
NYUAD researchers develop high throughput paper-based arrays of 3D tumor models
Credit: NYU Abu Dhabi Abu Dhabi, UAE, February 22: By engineering common filter papers, similar to coffee filters, a team of NYU Abu Dhabi researchers have created high throughput arrays of miniaturized 3D tumor models to replicate key aspects of tumor physiology, which are absent in traditional drug testing platforms. With the new paper-based technology, the formed tumor models can be safely cryopreserved and stored for prolonged periods for on-demand drug testing use. These cryopreservable tumor models could provide the pharmaceutical industry with an easy and low cost method for investig...
Source: eurekalert.org